سعر Xefo 8 mg 10 f.c. tabs 2026
الفئة: مضاد التهاب غير ستيرويدي
دواعي استعمال Xefo 8
- Short-term relief of acute mild to moderate pain.الفئة: AdultsHealth Products Regulatory Authority (HPRA), Ireland
- Symptomatic relief of pain and inflammation in osteoarthritis.الفئة: AdultsHealth Products Regulatory Authority (HPRA), Ireland
- Short-term relief of acute mild to moderate pain.Population: AdultsHealth Products Regulatory Authority (HPRA), Ireland
- Symptomatic relief of pain and inflammation in osteoarthritis.Population: AdultsHealth Products Regulatory Authority (HPRA), Ireland
معلومات الدواء
التفاصيل الكاملةالآثار الجانبيةSide effects
- About 20% of patients may experience adverse reactions; most frequent are nausea, dyspepsia, indigestion, abdominal pain, vomiting and diarrhoea (generally under 10%).نشرة دولية لنفس التركيبة · Health Products Regulatory Authority (HPRA), Ireland
- About 20% of patients may experience adverse reactions; most frequent are nausea, dyspepsia, indigestion, abdominal pain, vomiting and diarrhoea (generally under 10%).International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland
موانع الاستعمالContraindications
- Hypersensitivity to lornoxicam or excipients; thrombocytopenia; hypersensitivity (asthma, rhinitis, angioedema, urticaria) to other NSAIDs including aspirin; severe heart failure; GI, cerebrovascular or other bleeding disorders; history of NSAID-related GI bleeding/perforation; active or recurrent peptic ulcer; severe hepatic impairment; severe renal impairment (serum creatinine >700 µmol/L); third trimester of pregnancy.نشرة دولية لنفس التركيبة · Health Products Regulatory Authority (HPRA), Ireland
- Hypersensitivity to lornoxicam or excipients; thrombocytopenia; hypersensitivity (asthma, rhinitis, angioedema, urticaria) to other NSAIDs including aspirin; severe heart failure; GI, cerebrovascular or other bleeding disorders; history of NSAID-related GI bleeding/perforation; active or recurrent peptic ulcer; severe hepatic impairment; severe renal impairment (serum creatinine >700 µmol/L); third trimester of pregnancy.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland
تحذيرات واحتياطاتWarnings & precautions
- Use with careful risk-benefit assessment in mild to moderate renal impairment, coagulation disorders, hepatic impairment and in the elderly; avoid combination with other NSAIDs including COX-2 inhibitors; use the lowest effective dose for the shortest duration.نشرة دولية لنفس التركيبة · Health Products Regulatory Authority (HPRA), Ireland
- Use with careful risk-benefit assessment in mild to moderate renal impairment, coagulation disorders, hepatic impairment and in the elderly; avoid combination with other NSAIDs including COX-2 inhibitors; use the lowest effective dose for the shortest duration.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland
الحمل والرضاعةPregnancy & breastfeeding
- Contraindicated in the third trimester; should not be used in the first and second trimesters or during delivery because no clinical data on exposed pregnancies are available.نشرة دولية لنفس التركيبة · Health Products Regulatory Authority (HPRA), Ireland
- No human data; lornoxicam is excreted in rat milk in relatively high concentrations, so it should not be used in breastfeeding women.نشرة دولية لنفس التركيبة · Health Products Regulatory Authority (HPRA), Ireland
- Contraindicated in the third trimester; should not be used in the first and second trimesters or during delivery because no clinical data on exposed pregnancies are available.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland
- No human data; lornoxicam is excreted in rat milk in relatively high concentrations, so it should not be used in breastfeeding women.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland
تابع أسعار الأدوية أول بأول
بننشر كل يوم أسعار أدوية اتغيرت والبدائل الأرخص
المثائل (11)
كل المثائل والبدائلنفس المادة الفعالة والتركيز. اسأل الصيدلي قبل الاستبدال.
| الدواء | السعر | الفرق عن الأصلي |
|---|---|---|
| توبرانو 8مجم 20 اقراصToprano 8mg 20 f.c.tabDelta Pharma · أقراص مغلفة · 8 mgالأرخص | السعر20ج.م1ج.م للوحدة | الفرق عن الأصليأرخص 8ج.م (28.6%) |
| لورجيك 8 مجم 20 قرصLorgeque 8mg 20 f.c.tabspimaco misr") · أقراص مغلفة · 8 mg | السعر21ج.م1.05ج.م للوحدة | الفرق عن الأصليأرخص 7ج.م (25%) |
| نوكسيلورن 8مجم 30 قرصNoxilorn 8 mg 30 f.c.tabAUG Pharma · أقراص مغلفة · 8 mg | السعر27ج.م0.9ج.م للوحدة | الفرق عن الأصليأرخص 1ج.م (3.6%) |
| لورانوفيل 8مجم 20 قرصLoranovil 8mg 20 f.c. tabsCopad pharma · أقراص مغلفة · 8 mg | السعر31ج.م1.55ج.م للوحدة | الفرق عن الأصليأغلى 3ج.م (10.7%) |
| رويانوكسيكام 8 مجمRoyanoxicam 8 mg 20 film-coated tabletsMedizen Pharmaceutical Industries · أقراص مغلفة · 8 mg | السعر42ج.م2.1ج.م للوحدة | الفرق عن الأصليأغلى 14ج.م (50%) |
أدوية ذات صلة
نفس المادة الفعالة بتركيز آخر
منتجات أخرى من Takeda
المصادر
- السعر: قوائم أسعار الأدوية المنشورة في مصر.
- Health Products Regulatory Authority (HPRA), Ireland
تعليقات
لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.
أضف تعليقًا